Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition.

Orio L, Crespo I, López-Moreno JA, Reyes-Cabello C, Rodríguez de Fonseca F, Gómez de Heras R.

Pharmacol Biochem Behav. 2011 Apr;98(2):220-6. doi: 10.1016/j.pbb.2010.12.007. Epub 2010 Dec 14.

PMID:
21163296
[PubMed - indexed for MEDLINE]
2.

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.

J Neurosci. 2002 Nov 1;22(21):9612-7.

PMID:
12417686
[PubMed - indexed for MEDLINE]
Free Article
3.

Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control.

Son MH, Kim HD, Chae YN, Kim MK, Shin CY, Ahn GJ, Choi SH, Yang EK, Park KJ, Chae HW, Moon HS, Kim SH, Shin YG, Yoon SH.

Int J Obes (Lond). 2010 Mar;34(3):547-56. doi: 10.1038/ijo.2009.253. Epub 2009 Dec 22.

PMID:
20029379
[PubMed - indexed for MEDLINE]
4.

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, Dockray GJ.

J Neurosci. 2004 Mar 17;24(11):2708-15.

PMID:
15028763
[PubMed - indexed for MEDLINE]
Free Article
5.

Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.

Pavón FJ, Serrano A, Pérez-Valero V, Jagerovic N, Hernández-Folgado L, Bermúdez-Silva FJ, Macías M, Goya P, de Fonseca FR.

J Neuroendocrinol. 2008 May;20 Suppl 1:116-23. doi: 10.1111/j.1365-2826.2008.01693.x. Review.

PMID:
18426510
[PubMed - indexed for MEDLINE]
6.

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.

Duarte C, Alonso R, Bichet N, Cohen C, Soubrié P, Thiébot MH.

Neuropsychopharmacology. 2004 May;29(5):911-20.

PMID:
14694354
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.

De Vry J, Jentzsch KR.

Behav Pharmacol. 2004 Feb;15(1):13-20.

PMID:
15075622
[PubMed - indexed for MEDLINE]
9.

Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.

Ward SJ, Lefever TW, Rawls SM, Whiteside GT, Walker EA.

Psychopharmacology (Berl). 2009 Sep;206(1):155-65. doi: 10.1007/s00213-009-1592-6. Epub 2009 Jul 3.

PMID:
19575185
[PubMed - indexed for MEDLINE]
10.

Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.

Romanelli L, Palmery M, Tucci P, Amico MC, Morrone LA, Valeri P.

Neurotoxicology. 2005 Oct;26(5):819-27.

PMID:
15913779
[PubMed - indexed for MEDLINE]
11.

Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.

Tallett AJ, Blundell JE, Rodgers RJ.

Psychopharmacology (Berl). 2007 Nov;195(1):27-39. Epub 2007 Jul 19.

PMID:
17639351
[PubMed - indexed for MEDLINE]
12.

CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.

Hasanein P, Parviz M, Keshavarz M, Javanmardi K.

Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):439-49.

PMID:
17439413
[PubMed - indexed for MEDLINE]
13.

Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.

Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N.

Brain Res Bull. 2009 Mar 16;78(4-5):202-10. doi: 10.1016/j.brainresbull.2008.10.014. Epub 2008 Nov 25.

PMID:
19038314
[PubMed - indexed for MEDLINE]
14.

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.

Haller J, Varga B, Ledent C, Freund TF.

Behav Pharmacol. 2004 Jul;15(4):299-304.

PMID:
15252281
[PubMed - indexed for MEDLINE]
15.

The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.

Rutkowska M.

Acta Pol Pharm. 2004 Sep-Oct;61(5):401-3.

PMID:
15747698
[PubMed - indexed for MEDLINE]
Free Article
16.

Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.

Maccioni P, Pes D, Carai MA, Gessa GL, Colombo G.

Behav Pharmacol. 2008 May;19(3):197-209. doi: 10.1097/FBP.0b013e3282fe8888.

PMID:
18469537
[PubMed - indexed for MEDLINE]
17.

Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.

Malinen H, Hyytiä P.

Alcohol Clin Exp Res. 2008 Nov;32(11):1976-83. doi: 10.1111/j.1530-0277.2008.00786.x. Epub 2008 Sep 6.

PMID:
18782338
[PubMed - indexed for MEDLINE]
18.

Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.

Schoffelmeer AN, Hogenboom F, Wardeh G, De Vries TJ.

Neuropharmacology. 2006 Sep;51(4):773-81. Epub 2006 Jun 30.

PMID:
16806307
[PubMed - indexed for MEDLINE]
19.

A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour.

Thornton-Jones ZD, Kennett GA, Vickers SP, Clifton PG.

Psychopharmacology (Berl). 2007 Jul;193(1):1-9. Epub 2007 Mar 20.

PMID:
17372721
[PubMed - indexed for MEDLINE]
20.

Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.

Tallett AJ, Blundell JE, Rodgers JR.

Behav Pharmacol. 2007 Nov;18(7):591-600.

PMID:
17912043
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk